News

The Forbes Asia 100 to Watch list spotlights dynamic startups and small companies across the Asia-Pacific region that are increasingly focusing on AI and deep tech to innovate and thrive. Being included in this esteemed group, particularly within the Biotechnology & Healthcare category, affirms our position at the forefront of this crucial evolution. Founded in 2020 and led by our CEO, Sharon Chen, AlphaLife Sciences is headquartered in Singapore, a key hub for innovation as noted by Forbes.

Transforming R&D with AuroraPrime: Our AI Flagship

At the heart of our recognition is the AuroraPrime Platform, our leading AI-powered enterprise document authoring platform. AuroraPrime is specifically designed to transform life sciences R&D by accelerating cycles and boosting efficiency. This advanced generative AI platform delivers agentic solutions that revolutionize the creation of regulatory and medical documents across all phases of R&D, from pre-clinical and clinical to regulatory and safety areas.

The impact of AuroraPrime is clearly reflected in the tangible results achieved by industry leaders:

• Significant Reductions in First Draft Time: Our clients have seen an impressive 90% reduction for Clinical Study Reports (CSRs) and Protocols, and a 95% reduction for Safety Narratives.

• Substantial Overall Time Savings: This translates to 50% overall time savings for CSRs and Protocols, and a remarkable 70% for Safety Narratives. Overall, our solutions can reduce medical writing time by 30-90%, boosting productivity.

These proven time savings free up R&D leaders to focus on core innovation by automating routine tasks, significantly boosting research efficiency and productivity. For pharmaceutical companies, our AI writing solutions mean speeding up document creation for CSRs, Protocols, and Safety Narratives, ensuring compliance and quicker regulatory submissions.

Powering Precision and Compliance

AuroraPrime’s capabilities go far beyond just speed. Our platform is built on a robust GenAI architecture that combines advanced AI technologies for precise, compliant document creation. Key features include:

• AI Automation for swift and accurate medical document generation.

• Data Management that organizes data and templates for easy access and reuse.

• Seamless Integration with existing systems for consistency across platforms.

• Regulatory Compliance checks for accuracy and adherence to standards.

• Customizable Modules that adapt workflows and document types as needed.

Our solutions like AI-Copiloted Medical Writing Acceleration empower teams to:

• Streamline setup and drafting by using enterprise templates and syncing TFL data.

• Quickly create TFL summaries, reducing manual work.

• Enable one-click batch updates, ensuring documents are always current and compliant.

For regulatory documents, our AI-Powered Regulatory Document Automation automates creation across all R&D phases with GenAI, includes built-in GenAI QC benchmarking against "golden" standards, and allows for tailored quality metrics for task-specific evaluations. AuroraPrime even offers AI-powered translation solutions for regulatory documents, ensuring industry-standard quality with customizable memory, multi-format support, and cross-file consistency.

Trusted by Global Pharma Leaders

Our success is echoed by our customers. A Top 5 Global Pharmaceutical Company has stated, “AlphaLife Sciences sets the industry standard. Your innovative solutions are transformative—enhancing efficiency and quality across our operations”. Furthermore, a Top 3 Global Leading CRO highlighted, “By leveraging AlphaLife Sciences’ tools, we’ve achieved significant efficiency gains, particularly in content reuse. Starting with the CSR, we’ve streamlined workflows for the SAP and study protocols, saving time and reducing redundancy”. Another Top 10 Global Pharmaceutical Company confirmed a 30% time-saving with our tools, allowing them to focus more on strategic tasks while maintaining high-quality outputs.

This recognition by Forbes Asia is not just an award; it's a powerful validation of our vision to drive innovation in life sciences with AI excellence. Backed by leading technology partners like Microsoft, Google, and Nvidia, AuroraPrime is a unified, modular platform designed for scalability and low-code adaptability, empowering enterprises to achieve transformative outcomes.

We are incredibly proud of this achievement and deeply grateful to our dedicated team, our visionary customers, and our partners. Together, we are not just watching the future of life sciences; we are actively shaping it.

Stay tuned as AlphaLife Sciences continues to redefine what's possible in medical and regulatory content authoring!